Sanjivani Paranteral Ltd (SANJIVIN) is currently trading at 186.90 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Sanjivani Paranteral Limited is a WHO‑GMP certified Indian pharmaceutical manufacturer focused on sterile injectables and oral solid dosage forms, exporting to over 25 countries and operating manufacturing facilities in Navi Mumbai, Dehradun, Pune (SPL Infusion) and Prague (Alevia JV) while serving hospital and distributor channels in emerging markets. Q3 FY26 performance was robust: standalone revenue of INR208.6 million (up 20.3% YoY), EBITDA of INR38.8 million (up 35.7% YoY) and PAT of INR26.2 million (up 37.8% YoY), with exports contributing roughly 77% of revenue and consolidated numbers showing slightly stronger YoY growth driven by new subsidiaries. Margins tell a mixed story: gross margin compressed materially year‑on‑year due to higher COGS while EBITDA margin expanded to 18.4% driven by favourable product mix and lower other expenses, indicating the company can protect operating profitability through mix and cost control despite input cost pressure. The company is transitioning to a multi‑vertical platform — Pune infusion facility has started contributing commercially and Prague nutraceutical JV has begun commercial batches — and management is guiding a material revenue step‑up in FY27, supported by product portfolio expansion and strategic partnerships.

Over the past 52 weeks, Sanjivani Paranteral Ltd has traded between a low of ₹126.00 and a high of ₹263.95. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Sanjivani Paranteral Ltd has a market capitalization of approximately 236.72. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Sanjivani Paranteral Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 31.73 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 236.72 Cr, Sanjivani Paranteral Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Sanjivani Paranteral Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Sanjivani Paranteral Ltd is 31.73. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The company reported consolidated profit after tax of ₹2.49 crore for the quarter ended June 30, 2026, up from ₹1.73 crore in Q1 FY26.